ReviewThe Lancet regional health. Western Pacific2026
HPV vaccination policies and implementation for adolescents in low- and middle-income countries: a scoping review.
Review in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
22 authors.
Funding
Abstract
This scoping review mapped adolescent HPV vaccination policies across 84 low- and middle-income countries (LMICs) with national HPV immunization programs and synthesized implementation evidence through July 2025. Focusing on adolescents aged 9-14 years, we identified policy convergence in target age, school-based delivery, and free vaccination provision, alongside divergence in gender eligibility, vaccine type, and funding mechanisms across income levels. Nearly half of LMICs have adopted single-dose schedules, reflecting a clear trend toward dosing simplification. Despite these policy advances, only 9.8% of countries achieved the WHO 90% complete vaccination target among females by age 15. Coverage analysis suggested that school-based programs maintained more stable performance over time than health facility-based approaches. Implementation evidence identified four facilitating factors, while barriers varied by income level. School-based programs complemented by mixed delivery approaches and single-dose schedules may offer a promising pathway toward the 2030 cervical cancer elimination goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.